TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells

Lynette J Schedlich1, Vanessa M Yenson, Robert C Baxter

  • 1Kolling Institute of Medical Research, University of Sydney, Royal North Shore Hospital, Sydney, NSW 2065, Australia. lyn.schedlich@sydney.edu.au

Insights

Transforming growth factor-β (TGF-β) signaling induces insulin-like growth factor binding protein-3 (IGFBP-3) in osteosarcoma cells. This IGFBP-3 then inhibits cell growth by negatively regulating the type I IGF receptor (IGF1R) pathway.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Cancer Research

Background:

  • Transforming growth factor-β (TGF-β) and insulin-like growth factors (IGFs) signaling pathways are crucial in osteosarcoma cell proliferation.
  • Understanding the cross-talk between these pathways is vital for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of endogenous insulin-like growth factor binding protein-3 (IGFBP-3) in mediating cross-talk between TGF-β receptor and type I IGF receptor (IGF1R) signaling in MG-63 osteosarcoma cells.
  • To elucidate the regulatory mechanisms governing osteosarcoma cell growth.

Main Methods:

  • Utilized MG-63 osteosarcoma cell line.
  • Investigated the activation of Ras/Raf/MAPK pathway and expression of IGFBP-3.
  • Assessed the effects of IGFBP-3 on ERK1/2 and Akt activation.
  • Examined the impact of IGFBP-3 on cell cycle progression and proliferation.
  • Analyzed Smad2 phosphorylation and nuclear accumulation.

Main Results:

  • TGF-β1 indirectly activated the Ras/Raf/MAPK pathway and induced IGFBP-3 expression.
  • IGFBP-3 attenuated TGF-β1-induced activation of ERK1/2 and Akt, inhibiting cell cycle progression and proliferation.
  • Inhibition of IGF1R signaling blocked the effects of IGFBP-3.
  • Blocking TGF-β1-induced IGFBP-3 expression enhanced Smad2 phosphorylation and nuclear accumulation.

Conclusions:

  • TGF-β1 plays a significant role in osteosarcoma cell growth.
  • TGF-β1-induced IGFBP-3 acts as a negative-feedback mechanism to control cell growth.
  • This feedback loop functions by preventing the activation of the IGF1R pathway, thereby regulating osteosarcoma proliferation.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...